Table 1.
General clinical characteristics and etiology in patients of mercury-induced MN
| Case | Gender | Age, yr | Primary Disease | Etiology of Mercury Poisoning | Duration of Mercury Exposure, mo | Urinary Mercury Concentration, μg/L | Duration of Renal Symptoms, mo |
|---|---|---|---|---|---|---|---|
| 1 | F | 24 | rheumatoid arthritis | antirheumatoid pill | 60 | >400 | 12 |
| 2 | F | 45 | rheumatoid arthritis | antirheumatoid pill | 6 | 200 | 7 |
| 3 | F | 42 | rheumatoid arthritis | antirheumatoid pill | 5 | 48 | 2 |
| 4 | M | 15 | still disease | antirheumatoid pill | 60 | 22 | 2 |
| 5 | F | 37 | no | skin-lightening cream | 12 | 100 | 6 |
| 6 | F | 39 | no | skin-lightening cream | 8 | 12 | 1 |
| 7 | F | 33 | no | skin-lightening cream | 4 | 120 | 4 |
| 8 | F | 43 | no | skin-lightening cream | 8 | 18 | 3 |
| 9 | F | 38 | no | mercury-containing hair dye | 36 | 27 | 12 |
| 10 | F | 30 | tuberculosis of breast | mercury-containing drugs | 2 | >400 | 2 |
| 11 | F | 18 | no | mercury vapor | 7 | 35 | 3 |